A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers

NCT01558362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: 123I-CMICE-013

Sponsor

Ottawa Heart Institute Research Corporation

Collaborators

[object Object]